Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,433 | 48,875 | 94,172 | 231,900 | 272,350 |
| Marketable Securities | 275,043 | 301,614 | 295,218 | 234,178 | 125,979 |
| Receivables | 36,544 | 24,089 | 13,483 | 15,414 | 1,018 |
| Inventories | 39,228 | 39,705 | 24,752 | 19,326 | 13,927 |
| Other current assets | 1,129 | 1,031 | 1,334 | 796 | 0 |
| TOTAL | $446,596 | $424,800 | $442,539 | $513,324 | $419,427 |
| Non-Current Assets | |||||
| PPE Net | 98,871 | 116,567 | 8,557 | 9,801 | 10,275 |
| Investments And Advances | 0 | 201 | N/A | 0 | 24,380 |
| Intangibles | 4,355 | 4,977 | 6,425 | 8,404 | 9,332 |
| Other Non-Current Assets | 823 | 1,517 | 13,339 | 11,838 | 247 |
| TOTAL | $104,049 | $123,262 | $28,321 | $30,043 | $44,234 |
| Total Assets | $550,645 | $548,062 | $470,860 | $543,367 | $463,661 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,187 | 4,327 | 3,087 | 3,879 | 2,635 |
| Accrued Expenses | 64,971 | 49,395 | 36,278 | 31,068 | 22,162 |
| Other current liabilities | 1,531 | 1,588 | 2,033 | 4,640 | 6,412 |
| TOTAL | $97,763 | $77,188 | $46,107 | $40,646 | $31,997 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,002 | 4,813 | 3,148 | N/A | N/A |
| Other Non-Current Liabilities | 11,107 | 10,911 | 12,166 | 15,950 | 16,295 |
| TOTAL | $75,404 | $92,920 | $19,318 | $23,630 | $23,914 |
| Total Liabilities | $173,167 | $170,108 | $65,425 | $64,276 | $55,911 |
| Shareholders' Equity | |||||
| Common Shares | 1,187,696 | 1,200,218 | 1,185,309 | 1,177,051 | 944,328 |
| Retained earnings | -936,570 | -942,322 | -864,302 | -756,122 | -575,156 |
| Other shareholders' equity | -647 | -730 | -1,061 | -852 | -805 |
| TOTAL | $377,478 | $377,954 | $405,435 | $479,091 | $407,750 |
| Total Liabilities And Equity | $550,645 | $548,062 | $470,860 | $543,367 | $463,661 |